Revvity (NYSE:RVTY) Insider Tajinder Vohra Sells 7,330 Shares

Revvity Inc. (NYSE:RVTY) insider Tajinder Vohra sold 7,330 shares of the firm’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the transaction, the insider owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. The trade was a 52.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Revvity Stock Down 2.1%

Shares of NYSE RVTY opened at $143.60 on Friday. The company has a market capitalization of $16.02 billion, a P/E ratio of 68.38, a price-to-earnings-growth ratio of 2.67 and a beta of 1.09. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $149.52. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The company’s 50 day moving average price is $120.62 and its 200-day moving average price is $104.72.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. Revvity’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is 13.33%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on RVTY shares. KeyCorp upped their target price on Revvity from $125.00 to $165.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. UBS Group initiated coverage on Revvity in a report on Wednesday, September 9th. They set a “neutral” rating and a $140.00 price target on the stock. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $116.57.

Institutional Investors Weigh In On Revvity

Several hedge funds and other institutional investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company raised its holdings in shares of Revvity by 5.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 368,938 shares of the company’s stock worth $41,048,000 after acquiring an additional 20,278 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Revvity during the 2nd quarter valued at about $171,000. Nykredit A S bought a new stake in Revvity during the 2nd quarter worth approximately $358,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Revvity during the 2nd quarter worth approximately $823,000. Finally, Angeles Wealth Management LLC raised its stake in shares of Revvity by 2.0% in the second quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock worth $646,000 after purchasing an additional 112 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Revvity Company Profile

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.